financetom
Business
financetom
/
Business
/
US offers six companies contracts to make uranium fuel for nuclear plants
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
US offers six companies contracts to make uranium fuel for nuclear plants
Dec 10, 2024 12:32 PM

WASHINGTON, Dec 10 (Reuters) - The U.S. Energy

Department said on Tuesday it is offering initial contracts to

six companies to produce domestic uranium fuel for conventional

nuclear plants to generate electricity.

WHY IT'S IMPORTANT

The department is trying to kick-start a domestic uranium

fuel supply chain to reduce dependence on Russia, from which

U.S. reactors get about 25% of their enriched uranium in recent

years. The United States put a ban on the imports from Russia as

part of a package of sanctions on Moscow over its full scale

invasion of Ukraine. The ban allows waivers until 2028.

The U.S. is investigating uranium imports to see if China is

helping Russia circumvent the ban.

KEY QUOTE

"These contracts generated from this action will help spur

the safe and responsible build-out of uranium enrichment

capacity in the United States," said Michael Goff, principal

deputy assistant secretary for nuclear energy.

THE COMPANIES

The following companies won contracts: Centrus's

American Centrifuge Operating; General Matter; Global Laser

Enrichment; Urenco's Louisiana Energy Services; Laser Isotope

Separation Technologies and Orano Federal Services.

Four of those companies got initial U.S. contracts in

October to produce a more enriched fuel called high assay low

enriched uranium, or HALEU, to be used in smaller reactors that

are not yet commercial.

Conventional uranium fuel is up to 5% enriched while HALEU

is up to 20% enriched.

BY THE NUMBERS

The contracts at the start are for a minimum of $2 million.

They will last for up to 10 years with $2.7 billion available

for the program.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
J & J Snack Foods Fiscal Q4 Adjusted Earnings, Net Sales Drop
J & J Snack Foods Fiscal Q4 Adjusted Earnings, Net Sales Drop
Nov 17, 2025
08:16 AM EST, 11/17/2025 (MT Newswires) -- J & J Snack Foods ( JJSF ) reported fiscal Q4 adjusted earnings Monday of $1.58 per diluted share, down from $1.60 a year earlier. Three analysts polled by FactSet expected $1.24. Net sales for the quarter ended Sept. 27 were $410.2 million, down from $426.8 million a year earlier. Three analysts surveyed...
Market Chatter: Comerica Investor Pushes for More Details on Fifth Third Sale
Market Chatter: Comerica Investor Pushes for More Details on Fifth Third Sale
Nov 17, 2025
08:20 AM EST, 11/17/2025 (MT Newswires) -- Comerica ( CMA ) is facing pressure from HoldCo Asset Management to disclose more information about its agreement to be acquired by Fifth Third Bancorp ( FITB ) , with the activist investor calling the sale process flawed, Bloomberg reported, citing a HoldCo presentation. HoldCo says Comerica ( CMA ) failed to run...
Hut 8 to Sell 4 Natural Gas Power Plants to TransAlta in Ontario
Hut 8 to Sell 4 Natural Gas Power Plants to TransAlta in Ontario
Nov 17, 2025
08:18 AM EST, 11/17/2025 (MT Newswires) -- Hut 8 ( HUT ) said Monday it has agreed to sell its 310-megawatt portfolio of four natural gas-fired power plants in Ontario to TransAlta ( TAC ) . Financial terms were not disclosed. The four power plants are owned and operated by Far North Power, an entity created by Hut 8 (...
Johnson & Johnson to Buy Halda Therapeutics for $3.05 Billion in Cash
Johnson & Johnson to Buy Halda Therapeutics for $3.05 Billion in Cash
Nov 17, 2025
08:15 AM EST, 11/17/2025 (MT Newswires) -- Johnson & Johnson ( JNJ ) said Monday it has agreed to buy Halda Therapeutics for $3.05 billion in cash. The deal will likely close within the next few months, subject to antitrust regulatory approval and other closing conditions, Johnson & Johnson ( JNJ ) said. ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved